# Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

> **NCT02086916** · — · COMPLETED · sponsor: **Barts & The London NHS Trust** · enrollment: 122 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02086916
- **Lead sponsor:** Barts & The London NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-12
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02086916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02086916, "Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02086916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*